Guerbet, a new global leader en route to the future

15.11.2016 08:00

In 90 years the Group has built a success story fueled by innovation and international growth

Guerbet celebrates its 90th year with all its 2,600 employees and stakeholders. A year after doubling in size, following a major acquisition, the Group continues to grow as one of the leading players in medical imaging worldwide. The Group offers a full range of medical solutions and services – in CT scan, MRI and Interventional Radiology – ongoing investment in innovation and its production capacities, in addition to a network of subsidiaries and partners that ensure a presence in all the principal global markets.

A pioneer and a player in imaging of the future

Although the history of Guerbet dates back to 1901, with the discovery by Marcel Guerbet of the world’s first iodinated contrast agent, the official creation of the pharmaceutical company dates from 15 November 1926. In 1965 it became SA Laboratoires André Guerbet. From a headcount of 150 at that time, its staff grew to 1,000 in 1990, 1,500 in 2015 and 2,600 today, following the acquisition of Mallinckrodt’s “Contrast Media and Delivery Systems” business, finalized a year ago. With this acquisition Guerbet has reached a critical size in each segment and geographical zone with the ambition of entering the world’s top three.

In line with this celebration Guerbet’s sites worldwide will be organizing events associating their employees and their external audiences over the coming months.

Campaign #Guerbet90 to follow on Twitter: @GuerbetGroup and Instagram: @guerbetgroup 

Find out more

Read the press release


Follow us!  ӏ  ӏ  ӏ